Identification of human herpes virus 1 encoded microRNAs in biopsy samples of lower esophageal sphincter muscle during peroral endoscopic myotomy for esophageal achalasia.


Journal

Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society
ISSN: 1443-1661
Titre abrégé: Dig Endosc
Pays: Australia
ID NLM: 9101419

Informations de publication

Date de publication:
Jan 2020
Historique:
received: 13 05 2019
accepted: 16 07 2019
pubmed: 22 7 2019
medline: 6 11 2020
entrez: 21 7 2019
Statut: ppublish

Résumé

Esophageal achalasia is a rare chronic debilitating disorder characterized by incomplete lower esophageal sphincter (LES) relaxation and abnormal peristalsis as a result of myenteric plexus degeneration. Although complex interactions among immunity, viruses and inheritance have been proposed, its causes remain unknown. MicroRNAs (miRs) play crucial roles in the regulation of gene expression during pathophysiological processes. Certain viruses such as herpes simplex virus (HSV) encode miRs derived from their own genomes. To determine the underlying relationship of miRNAs to achalasia, we analyzed the expression profile of miRNAs using biopsy samples obtained from LES muscle during peroral endoscopic myotomy. Peroral LES muscle biopsy sampling was uneventfully carried out in our case series of achalasia. Control biopsy tissues were also obtained from LES muscle of patients without symptoms relating to abnormal esophageal motility whose esophagogastric junction was surgically excised. RNA was extracted from biopsy specimens and analyzed using a microarray. Differentially expressed miRNAs in achalasia patients compared to controls were identified and analyzed using reverse transcription quantitative polymerase chain reaction. HSV-1-derived hsv1-miR-H1 and -H18 was significantly overexpressed in achalasia cohorts compared to controls. Correlations between the expression levels of viral miR and the patients' clinical characteristics including achalasia morphological type, dilatation grading, and disease duration were not identified. Further studies with a larger sample size are needed to replicate the current heuristic identification of neurotropic viral miRs and unravel their functional significance in order to provide new insight linking neurodegenerative etiology in achalasia.

Identifiants

pubmed: 31325192
doi: 10.1111/den.13491
doi:

Substances chimiques

MicroRNAs 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

136-142

Informations de copyright

© 2019 Japan Gastroenterological Endoscopy Society.

Références

Sato H, Yokomichi H, Takahashi K et al. Epidemiological analysis of achalasia in Japan using a large-scale claims database. J. Gastroenterol. 2019; 54 (7): 621-7.
Furuzawa-Carballeda J, Torres-Landa S, Valdovinos MÁ, Coss-Adame E, Martín Del Campo LA, Torres-Villalobos G. New insights into the pathophysiology of achalasia and implications for future treatment. World J. Gastroenterol. 2016; 22: 7892-907.
Inoue H, Shiwaku H, Iwakiri K et al. Clinical practice guidelines for peroral endoscopic myotomy. Dig. Endosc. 2018; 30: 563-79.
Isomoto H, Ikebuchi Y. Japanese guidelines for peroral endoscopic myotomy: 1st edition. Dig. Endosc. 2019; 31: 27-9.
Sato H, Inoue H, Ikeda H et al. In vivo histopathological assessment of the muscularis propria in achalasia by using endocytoscopy (with video). Endosc. Int. Open 2014; 2: E178-82.
Nakajima N, Sato H, Takahashi K et al. Muscle layer histopathology and manometry pattern of primary esophageal motility disorders including achalasia. Neurogastroenterol. Motil. 2017; 29: e12968.
Ghoshal UC, Daschakraborty SB, Singh R. Pathogenesis of achalasia cardia. World J. Gastroenterol. 2012; 18: 3050-7.
Pressman A, Behar J. Etiology and pathogenesis of idiopathic achalasia. J. Clin. Gastroenterol. 2017; 51: 195-202.
Bernier A, Sagan SM. The diverse roles of microRNAs at the host-virus interface. Viruses 2018; 10: E440.
Piedade D, Azevedo-Pereira JM. The role of microRNAs in the pathogenesis of herpesvirus infection. Viruses 2016; 8: E156.
Shoji H, Isomoto H, Yoshida A et al. MicroRNA-130a is highly expressed in the esophageal mucosa of achalasia patients. Exp. Ther. Med. 2017; 14: 898-904.
Japan Esophageal Society. Descriptive rules for achalasia of the esophagus, June 2012: 4th edition. Esophagus 2017; 14: 275-89.
Kilic A, Krasinskas AM, Owens SR, Luketich JD, Landreneau RJ, Schuchert MJ. Variations in inflammation and nerve fiber loss reflect different subsets of achalasia patients. J. Surg. Res. 2007; 143: 177-82.
Sato H, Takahashi K, Mizuno KI et al. Esophageal motility disorders: new perspectives from high-resolution manometry and histopathology. J. Gastroenterol. 2018; 53: 484-93.
Sato H, Nakajima N, Hasegawa G et al. Immunohistochemical differentiation of eosinophilic esophageal myositis from eosinophilic esophagitis. J. Gastroenterol. Hepatol. 2017; 32: 106-13.
Gockel I, Becker J, Wouters MM et al. Common variants in the HLA-DQ region confer susceptibility to idiopathic achalasia. Nat. Genet. 2014; 46(8): 901-4.
Cokarić Brdovčak M, Zubković A, Jurak I. Herpes simplex virus 1 deregulation of host microRNAs. Noncoding RNA 2018; 4: E36.
Facco M, Brun P, Baesso I et al. T cells in the myenteric plexus of achalasia patients show a skewed TCR repertoire and react to HSV-1 antigens. Am. J. Gastroenterol. 2008; 103: 1598-609.
Furuzawa-Carballeda J, Aguilar-León D, Gamboa-Domínguez A et al. Achalasia-an autoimmune inflammatory disease: a cross-sectional study. J. Immunol. Res. 2015; 2015: 729217.
Zheng K, Liu Q, Wang S et al. HSV-1-encoded microRNA miR-H1 targets Ubr1 to promote accumulation of neurodegeneration-associated protein. Virus Genes 2018; 54: 343-50.

Auteurs

Yuichiro Ikebuchi (Y)

Digestive Center, Showa University Koto-Toyusu Hospital, Tokyo, Japan.
Division of Medicine and Clinical Science, Department of Multidisciplinary Internal Medicine, Faculty of Medicine, Tottori University, Japan.

Tsutomu Kanda (T)

Division of Medicine and Clinical Science, Department of Multidisciplinary Internal Medicine, Faculty of Medicine, Tottori University, Japan.

Haruo Ikeda (H)

Digestive Center, Showa University Koto-Toyusu Hospital, Tokyo, Japan.

Akira Yoshida (A)

Division of Medicine and Clinical Science, Department of Multidisciplinary Internal Medicine, Faculty of Medicine, Tottori University, Japan.

Takuki Sakaguchi (T)

Digestive Center, Showa University Koto-Toyusu Hospital, Tokyo, Japan.
Division of Medicine and Clinical Science, Department of Multidisciplinary Internal Medicine, Faculty of Medicine, Tottori University, Japan.

Shigetoshi Urabe (S)

Department of Gastroenterology and Hepatology, Nagasaki University Hospital, Nagasaki, Japan.

Hitomi Minami (H)

Department of Gastroenterology and Hepatology, Nagasaki University Hospital, Nagasaki, Japan.

Kazuhiko Nakao (K)

Department of Gastroenterology and Hepatology, Nagasaki University Hospital, Nagasaki, Japan.

Satoshi Kuwamoto (S)

Department of Pathology, Tottori University Hospital, Tottori, Japan.

Haruhiro Inoue (H)

Digestive Center, Showa University Koto-Toyusu Hospital, Tokyo, Japan.

Hajime Isomoto (H)

Division of Medicine and Clinical Science, Department of Multidisciplinary Internal Medicine, Faculty of Medicine, Tottori University, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH